Ottobock
Ottobock is a privately held German medical device company that manufactures and distributes prosthetics, orthotics, wheelchairs, and the Exopulse Mollii Suit — a 58-electrode wearable neurostimulation device for spasticity management — to patients with neurological conditions and the clinicians who serve them.
- Company typePrivate
- Founded2009
- HeadquartersDanderyd, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ottobock does
Ottobock SE & Co. KGaA is a privately held German medical device company headquartered in Duderstadt, Germany, that designs, manufactures, and distributes mobility and rehabilitation products across three core hardware categories: prosthetic devices, orthotic devices, and wheelchairs and mobility devices. The company is identified as a key market player in the orthopedic prosthetics space alongside Össur hf and operates in a market projected to grow from USD 2.25B in 2025 to USD 3.36B by 2033 at a 5.16% CAGR. The Exopulse Mollii Suit, manufactured by the Sweden-based legal entity EXONEURAL NETWORK AB (Solna), is a near full-body wearable assistive device with 58 embedded electrodes that delivers mild neurostimulation to relax spastic muscles and relieve related pain for patients with cerebral palsy, multiple sclerosis, stroke, and other neurological conditions. It is intended for one hour of use every other day and positioned as a drug-free, non-invasive alternative to pharmacologic spasticity management.
The company monetizes through one-time hardware sales of prosthetics, orthotics, and wheelchairs, with Exopulse Mollii Suit pricing varying by geography, patient age, diagnosis, and insurance coverage; specific pricing is not publicly disclosed and prospective customers must request it via a contact form. Ottobock distributes through a clinical sales motion comprising company-owned Patient Care Centers (via subsidiary Ottobock OBA), an authorized network of specially trained clinics and rehabilitation facilities in Europe, and a global healthcare professional network, supported by a clinic locator tool. The company is owned by the Otto Bock family foundation, participates as a strategic institutional investor in adjacent neurotechnology (e.g., the EUR 50M+ ONWARD Medical placement in October 2025), and has signaled plans that include a public listing. Geographic reach spans Europe, North America, Asia-Pacific, and EMEA, though the Exopulse line is currently limited to Europe and is not FDA approved.
Ottobock firmographics
Firmographics- Name
- Ottobock
- Legal name
- Ottobock SE & Co. KGaA
- Website
- https://exopulse.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ottobock is a privately held German medical device company that manufactures and distributes prosthetics, orthotics, wheelchairs, and the Exopulse Mollii Suit — a 58-electrode wearable neurostimulation device for spasticity management — to patients with neurological conditions and the clinicians who serve them.
- Ownership category
- akta.pro rank
Ottobock industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI)
- akta.pro secondary industries
- Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)
Keywords
Where Ottobock is headquartered
LocationHeadquarters
- HQ city
- Danderyd
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Ottobock business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Prosthetic Devices: Manufacture and sale of orthopedic prosthetic devices including artificial limbs and components
- Orthotic Devices: Production and sale of orthotic devices including braces, supports, and the Exopulse Mollii Suit for spasticity management
- Wheelchairs and Mobility Devices: Sale of wheelchairs and other mobility assistance products
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | Exopulse Mollii Suit - Variable pricing based on patient factors |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Ottobock product offering
Product offeringCore offering
Ottobock manufactures and sells orthopedic medical devices including prosthetics (artificial limbs and components), orthotics (braces, supports, and the Exopulse Mollii Suit for spasticity management), wheelchairs, and mobility devices. The Exopulse Mollii Suit is a wearable near full-body assistive device with 58 embedded electrodes that deliver mild, imperceptible electrical neurostimulation signals to relax spastic muscles and relieve related pain in patients with cerebral palsy, multiple sclerosis, stroke, and other neurological conditions. The company also operates Patient Care Centers and distributes through authorized clinics and rehabilitation facilities across Europe and other global markets.
Product overview
Ottobock offers mobility solutions including prosthetics, orthotics, wheelchairs, and patient care centers. The primary product identified in the source material is the Exopulse Mollii Suit, a neurostimulation-based wearable device for near full-body spasticity management. The company also manufactures traditional prosthetic and orthotic devices, and provides wheelchair solutions and patient care services across Europe.
Differentiator
Problem solved
Functional benefit
Brands
- Exopulse: Wearable neurorehabilitation product line including the Exopulse Mollii Suit for spasticity management
Products and services
- Exopulse Mollii Suit
- Prosthetic Devices
- Orthotic Devices
- Wheelchairs and Mobility Devices
- Patient Care Centers
Quantifiable outcome
- Wearing the Exopulse Mollii Suit for one hour improves balance, gait, and stability in users with multiple sclerosis
- +1 more outcomes
Companies that use Ottobock
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Ottobock technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Ottobock partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Ottobock competitors and assessment
Company assessmentEmerging players
- Ekso Bionics: Ekso Bionics develops robotic exoskeletons for stroke, spinal cord injury, and neurorehabilitation. Adjacent to the Mollii Suit as a wearable rehabilitation technology targeting similar neurological patient populations.
- Cyberdyne: Cyberdyne develops the Hybrid Assistive Limb (HAL) robotic exoskeleton for neurological rehabilitation. Comparable as an emerging wearable rehabilitation technology targeting motor function recovery in similar patient populations.
Broad incumbents
- Medtronic: Medtronic operates one of the largest neuromodulation divisions globally, with spinal cord stimulators, deep brain stimulators, and other implanted neurostimulation devices. A broad incumbent in the broader neurostimulation category.
- Boston Scientific: Boston Scientific's Neuromodulation division offers spinal cord stimulators and other implantable neurostimulation systems. Comparable as a broad medtech incumbent competing in the broader neurostimulation market.
- Abbott Neuromodulation: Abbott's Neuromodulation business (formerly St. Jude Medical) develops spinal cord stimulation and dorsal root ganglion therapy devices. A large incumbent in implantable neurostimulation competing in adjacent therapeutic categories.
Direct peers
- Saebo: Saebo specializes in stroke rehabilitation products, including electrical stimulation devices (SaeboStim) and orthotic supports for upper extremities. Directly comparable as a neurostimulation and rehab device specialist targeting the same patient base.
- Hocoma: Hocoma is a Swiss neurorehabilitation technology company developing robotic and sensor-based devices for gait, balance, and movement therapy. Its products target the same neurological patient population (stroke, MS, CP) that the Exopulse Mollii Suit addresses.
- Allard International: Allard is a Swedish-based manufacturer of orthopedic braces and supports for neurological and orthopedic conditions. Comparable as a direct peer in orthotic devices for spasticity management and post-stroke/CP rehabilitation.
- Össur hf. Össur is a global leader in orthotics, prosthetics, and compression therapy, directly comparable to Ottobock's core prosthetic and orthotic device business. Both are repeatedly cited as the two leading players in the orthopedic prosthetic device market.
- Bioness: Bioness manufactures wearable neurostimulation devices (e.g., L300 Go, H200 Wireless) for foot drop, hand function, and rehabilitation. Directly overlaps with the Exopulse Mollii Suit in providing electrical stimulation therapy for spasticity and motor recovery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Ottobock social profiles
Digital presenceOttobock financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ottobock leadership team
Management profileNumber of profiles
Ottobock subsidiaries and ownership
Company hierarchySubsidiaries1 record
Ottobock funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ottobock M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ottobock
What does Ottobock do?
Ottobock manufactures and sells orthopedic medical devices including prosthetics (artificial limbs and components), orthotics (braces, supports, and the Exopulse Mollii Suit for spasticity management), wheelchairs, and mobility devices. The Exopulse Mollii Suit is a wearable near full-body assistive device with 58 embedded electrodes that deliver mild, imperceptible electrical neurostimulation signals to relax spastic muscles and relieve related pain in patients with cerebral palsy, multiple sclerosis, stroke, and other neurological conditions. The company also operates Patient Care Centers and distributes through authorized clinics and rehabilitation facilities across Europe and other global markets.
Is Ottobock a public or private company?
Ottobock is a private company. It is classified as family owned and is currently operating.
When was Ottobock founded?
Ottobock was founded in 2009. It employs 11 to 50 people.
Where is Ottobock based?
Ottobock is headquartered in Danderyd, Sweden, in the Europe region.
How does Ottobock make money?
Three revenue lines are on record. Prosthetic Devices are the primary driver. The others are orthotic Devices and wheelchairs and Mobility Devices.
Who are Ottobock's main competitors?
Emerging players on record are Ekso Bionics and Cyberdyne. Broad incumbents are Medtronic, Boston Scientific and Abbott Neuromodulation. Direct peers are Saebo, Hocoma, Allard International, Össur hf. and Bioness.
Does Ottobock have an API?
No public API is recorded for Ottobock.
What industry is Ottobock in?
Ottobock's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAI, Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses), with a secondary code of HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports). Its NAICS code is 339113 and its SIC code is 3842.